<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36362341</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>21</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>04</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Hemizygous Granzyme A Mice Expressing the hSOD1G93A Transgene Show Slightly Extended Lifespan.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">13554</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms232113554</ELocationID><Abstract><AbstractText>Granzyme A (gzmA), a serine protease involved in the modulation of the inflammatory immune response, is found at an elevated level in the serum from ALS patients. However, the influence of gzmA on the progression of ALS remains unclear. The aim of our work was to assess whether the absence of gzmA in an ALS murine model could help slow down the progression of the disease. Homozygous and hemizygous gzmA-deficient mice expressing the hSOD1G93A transgene were generated, and survival of these mice was monitored. Subsequently, gene and protein expression of inflammatory and oxidative stress markers was measured in the spinal cord and quadriceps of these mice. We observed the longest lifespan in gzmA+/- mice. GzmA gene and protein expression was downregulated in the spinal cord and serum from gmzA+/- mice, confirming that the increased survival of hemizygous mice is correlated with lower levels of gzmA. In addition, mRNA and protein levels of glutathione reductase (GSR), involved in oxidative stress, were found downregulated in the spinal cord and quadriceps of gmzA+/- mice, together with lower IL-1&#x3b2; and IL-6 mRNA levels in hemyzigous mice. In summary, our findings indicate for the first time that reduced levels, but not the absence, of gzmA could slightly ameliorate the disease progression in this animal model.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moreno-Martinez</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7277-4318</Identifier><AffiliationInfo><Affiliation>LAGENBIO, Faculty of Veterinary, University of Zaragoza, Miguel Servet 177, 50013 Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Centre of Arag&#xf3;n (CIBA), Arag&#xf3;n Health Research Institute (IIS Arag&#xf3;n), 50009 Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AgriFood Institute of Aragon-IA2 (UNIZAR-CITA), 50013 Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santiago</LastName><ForeName>Llipsy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Biomedical Research Centre of Arag&#xf3;n (CIBA), Arag&#xf3;n Health Research Institute (IIS Arag&#xf3;n), 50009 Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Torre</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7955-7164</Identifier><AffiliationInfo><Affiliation>LAGENBIO, Faculty of Veterinary, University of Zaragoza, Miguel Servet 177, 50013 Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Centre of Arag&#xf3;n (CIBA), Arag&#xf3;n Health Research Institute (IIS Arag&#xf3;n), 50009 Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AgriFood Institute of Aragon-IA2 (UNIZAR-CITA), 50013 Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Ana Cristina</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0001-5193-7782</Identifier><AffiliationInfo><Affiliation>LAGENBIO, Faculty of Veterinary, University of Zaragoza, Miguel Servet 177, 50013 Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Centre of Arag&#xf3;n (CIBA), Arag&#xf3;n Health Research Institute (IIS Arag&#xf3;n), 50009 Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AgriFood Institute of Aragon-IA2 (UNIZAR-CITA), 50013 Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pardo</LastName><ForeName>Juli&#xe1;n</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Biomedical Research Centre of Arag&#xf3;n (CIBA), Arag&#xf3;n Health Research Institute (IIS Arag&#xf3;n), 50009 Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osta</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5687-6704</Identifier><AffiliationInfo><Affiliation>LAGENBIO, Faculty of Veterinary, University of Zaragoza, Miguel Servet 177, 50013 Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Centre of Arag&#xf3;n (CIBA), Arag&#xf3;n Health Research Institute (IIS Arag&#xf3;n), 50009 Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AgriFood Institute of Aragon-IA2 (UNIZAR-CITA), 50013 Zaragoza, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PI21/00372</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>CB18/05/0037</GrantID><Agency>Biomedical Research Networking Center on Neurodegenerative Diseases</Agency><Country/></Grant><Grant><GrantID>21-23</GrantID><Agency>Consolidated Groups from Gobierno de Arag&#xf3;n.</Agency><Country/></Grant><Grant><Agency>Multidisciplinary Digital Publishing Institute (Switzerland)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber><NameOfSubstance UI="D053804">Granzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053804" MajorTopicYN="N">Granzymes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019076" MajorTopicYN="N">Transgenes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SOD1G93A mouse</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">glutathione reductase</Keyword><Keyword MajorTopicYN="N">granzyme A</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>1</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36362341</ArticleId><ArticleId IdType="pmc">PMC9655466</ArticleId><ArticleId IdType="doi">10.3390/ijms232113554</ArticleId><ArticleId IdType="pii">ijms232113554</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic Lateral Sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Phani S., Re D.B., Przedborski S. The Role of the Innate Immune System in ALS. Front. Pharmacol. 2012;3:150. doi: 10.3389/fphar.2012.00150.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2012.00150</ArticleId><ArticleId IdType="pmc">PMC3418523</ArticleId><ArticleId IdType="pubmed">22912616</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff R.M. How Neuroinflammation Contributes to Neurodegeneration. Science. 2016;353:777&#x2013;783. doi: 10.1126/science.aag2590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aag2590</ArticleId><ArticleId IdType="pubmed">27540165</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wang F. Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications. Front. Immunol. 2017;8:1005. doi: 10.3389/fimmu.2017.01005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01005</ArticleId><ArticleId IdType="pmc">PMC5567007</ArticleId><ArticleId IdType="pubmed">28871262</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues Lima-Junior J., Sulzer D., Lindestam Arlehamn C.S., Sette A. The Role of Immune-Mediated Alterations and Disorders in ALS Disease. Hum. Immunol. 2021;82:155&#x2013;161. doi: 10.1016/j.humimm.2021.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2021.01.017</ArticleId><ArticleId IdType="pmc">PMC7942756</ArticleId><ArticleId IdType="pubmed">33583639</ArticleId></ArticleIdList></Reference><Reference><Citation>Piancone F., La Rosa F., Marventano I., Saresella M., Clerici M. The Role of the Inflammasome in Neurodegenerative Diseases. Molecules. 2021;26:953. doi: 10.3390/molecules26040953.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26040953</ArticleId><ArticleId IdType="pmc">PMC7916884</ArticleId><ArticleId IdType="pubmed">33670164</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooten K.G., Beers D.R., Zhao W., Appel S.H. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2015;12:364&#x2013;375. doi: 10.1007/s13311-014-0329-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-014-0329-3</ArticleId><ArticleId IdType="pmc">PMC4404435</ArticleId><ArticleId IdType="pubmed">25567201</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff J.R., Simpson E.P., Appel S.H. Neuroinflammatory Mechanisms in Amyotrophic Lateral Sclerosis Pathogenesis. Curr. Opin. Neurol. 2018;31:635&#x2013;639. doi: 10.1097/WCO.0000000000000599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000599</ArticleId><ArticleId IdType="pubmed">30048339</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo S., Wang H., Yin Y. Microglia Polarization From M1 to M2 in Neurodegenerative Diseases. Front. Aging Neurosci. 2022;14:815347. doi: 10.3389/fnagi.2022.815347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.815347</ArticleId><ArticleId IdType="pmc">PMC8888930</ArticleId><ArticleId IdType="pubmed">35250543</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X. Motor Neuron Degeneration in Mice That Express a Human Cu, Zn Superoxide Dismutase Mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeyachandran A., Mertens B., McKissick E.A., Mitchell C.S. Type I vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression. Front. Cell. Neurosci. 2015;9:462. doi: 10.3389/fncel.2015.00462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00462</ArticleId><ArticleId IdType="pmc">PMC4664727</ArticleId><ArticleId IdType="pubmed">26648846</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Cao C., Qin X.-Y., Yu Y., Yuan J., Zhao Y., Cheng Y. Increased Peripheral Blood Inflammatory Cytokine Levels in Amyotrophic Lateral Sclerosis: A Meta-Analysis Study. Sci. Rep. 2017;7:9094. doi: 10.1038/s41598-017-09097-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09097-1</ArticleId><ArticleId IdType="pmc">PMC5567306</ArticleId><ArticleId IdType="pubmed">28831083</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Mart&#xed;nez L., De La Torre M., Toivonen J.M., Zaragoza P., Garc&#xed;a-Redondo A., Calvo A.C., Osta R. Circulating Cytokines Could Not Be Good Prognostic Biomarkers in a Mouse Model of Amyotrophic Lateral Sclerosis. Front. Immunol. 2019;10:801. doi: 10.3389/fimmu.2019.00801.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00801</ArticleId><ArticleId IdType="pmc">PMC6473074</ArticleId><ArticleId IdType="pubmed">31031774</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dyke J.M., Smit-Oistad I.M., Macrander C., Krakora D., Meyer M.G., Suzuki M. Macrophage-Mediated Inflammation and Glial Response in the Skeletal Muscle of a Rat Model of Familial Amyotrophic Lateral Sclerosis (ALS) Exp. Neurol. 2016;277:275&#x2013;282. doi: 10.1016/j.expneurol.2016.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.01.008</ArticleId><ArticleId IdType="pmc">PMC4762214</ArticleId><ArticleId IdType="pubmed">26775178</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y., Kim S., Cui X., Zheng L., Oh S.J., Anderson T., AlSharabati M., Kazamel M., Volpicelli-Daley L., Bamman M.M., et al. Transforming Growth Factor Beta (TGF-&#x3b2;) Is a Muscle Biomarker of Disease Progression in ALS and Correlates with Smad Expression. PLoS ONE. 2015;10:e0138425. doi: 10.1371/journal.pone.0138425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0138425</ArticleId><ArticleId IdType="pmc">PMC4574401</ArticleId><ArticleId IdType="pubmed">26375954</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata T., Akiyama H., Yamada T., McGeer P.L. Immunologic Reactions in Amyotrophic Lateral Sclerosis Brain and Spinal Cord Tissue. Am. J. Pathol. 1992;140:691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886170</ArticleId><ArticleId IdType="pubmed">1347673</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt J.I., Tajti J., Appel S.H. Lymphocytic Infiltrates in the Spinal Cord in Amyotrophic Lateral Sclerosis. Arch. Neurol. 1993;50:30&#x2013;36. doi: 10.1001/archneur.1993.00540010026013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1993.00540010026013</ArticleId><ArticleId IdType="pubmed">8093428</ArticleId></ArticleIdList></Reference><Reference><Citation>Melzer N., Meuth S.G., Wiendl H. CD8+ T Cells and Neuronal Damage: Direct and Collateral Mechanisms of Cytotoxicity and Impaired Electrical Excitability. FASEB J. 2009;23:3659&#x2013;3673. doi: 10.1096/fj.09-136200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-136200</ArticleId><ArticleId IdType="pubmed">19567369</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Lostao L., Anel A., Pardo J. How Do Cytotoxic Lymphocytes Kill Cancer Cells? Clin. Cancer Res. 2015;21:5047&#x2013;5056. doi: 10.1158/1078-0432.CCR-15-0685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-15-0685</ArticleId><ArticleId IdType="pubmed">26567364</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner C.T., Lim D., Granville D.J. Granzyme B in Skin Inflammation and Disease. Matrix Biol. 2019;75&#x2013;76:126&#x2013;140. doi: 10.1016/j.matbio.2017.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2017.12.005</ArticleId><ArticleId IdType="pubmed">29247692</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias M., Mart&#xed;nez-Lostao L., Santiago L., Ferrandez A., Granville D.J., Pardo J. The Untold Story of Granzymes in Oncoimmunology: Novel Opportunities with Old Acquaintances. Trends Cancer. 2017;3:407&#x2013;422. doi: 10.1016/j.trecan.2017.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trecan.2017.04.001</ArticleId><ArticleId IdType="pubmed">28718416</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell R.A., Franks Z., Bhatnagar A., Rowley J.W., Manne B.K., Supiano M.A., Schwertz H., Weyrich A.S., Rondina M.T. Granzyme A in Human Platelets Regulates the Synthesis of Proinflammatory Cytokines by Monocytes in Aging. J. Immunol. 2018;200:295&#x2013;304. doi: 10.4049/jimmunol.1700885.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1700885</ArticleId><ArticleId IdType="pmc">PMC5736423</ArticleId><ArticleId IdType="pubmed">29167233</ArticleId></ArticleIdList></Reference><Reference><Citation>Metkar S.S., Menaa C., Pardo J., Wang B., Wallich R., Freudenberg M., Kim S., Raja S.M., Shi L., Simon M.M., et al. Human and Mouse Granzyme A Induce a Proinflammatory Cytokine Response. Immunity. 2008;29:720&#x2013;733. doi: 10.1016/j.immuni.2008.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2008.08.014</ArticleId><ArticleId IdType="pubmed">18951048</ArticleId></ArticleIdList></Reference><Reference><Citation>van Daalen K.R., Reijneveld J.F., Bovenschen N. Modulation of Inflammation by Extracellular Granzyme A. Front. Immunol. 2020;11:931. doi: 10.3389/fimmu.2020.00931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00931</ArticleId><ArticleId IdType="pmc">PMC7248576</ArticleId><ArticleId IdType="pubmed">32508827</ArticleId></ArticleIdList></Reference><Reference><Citation>Garz&#xf3;n-Titua&#xf1;a M., Sierra-Monz&#xf3;n J.L., Comas L., Santiago L., Khaliulina-Ushakova T., Uranga-Murillo I., Ramirez-Labrada A., Tapia E., Morte-Romea E., Algarate S., et al. Granzyme A Inhibition Reduces Inflammation and Increases Survival during Abdominal Sepsis. Theranostics. 2021;11:3781&#x2013;3795. doi: 10.7150/thno.49288.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.49288</ArticleId><ArticleId IdType="pmc">PMC7914344</ArticleId><ArticleId IdType="pubmed">33664861</ArticleId></ArticleIdList></Reference><Reference><Citation>Coque E., Salsac C., Espinosa-Carrasco G., Varga B., Degauque N., Cadoux M., Crab&#xe9; R., Virenque A., Soulard C., Fierle J.K., et al. Cytotoxic CD8 + T Lymphocytes Expressing ALS-Causing SOD1 Mutant Selectively Trigger Death of Spinal Motoneurons. Proc. Natl. Acad. Sci. USA. 2019;116:2312&#x2013;2317. doi: 10.1073/pnas.1815961116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1815961116</ArticleId><ArticleId IdType="pmc">PMC6369778</ArticleId><ArticleId IdType="pubmed">30674678</ArticleId></ArticleIdList></Reference><Reference><Citation>I&#x142;&#x17c;ecka J. Granzymes A and B Levels in Serum of Patients with Amyotrophic Lateral Sclerosis. Clin. Biochem. 2011;44:650&#x2013;653. doi: 10.1016/j.clinbiochem.2011.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2011.02.006</ArticleId><ArticleId IdType="pubmed">21349256</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Eck J.A., Shan L., Meeldijk J., Hack C.E., Bovenschen N. A Novel Proinflammatory Role for Granzyme A. Cell Death Dis. 2017;8:e2630. doi: 10.1038/cddis.2017.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2017.56</ArticleId><ArticleId IdType="pmc">PMC5386495</ArticleId><ArticleId IdType="pubmed">28230859</ArticleId></ArticleIdList></Reference><Reference><Citation>Duvall M.G., Barnig C., Cernadas M., Ricklefs I., Krishnamoorthy N., Grossman N.L., Bhakta N.R., Fahy J.V., Bleecker E.R., Castro M., et al. Natural Killer Cell&#x2013;Mediated Inflammation Resolution Is Disabled in Severe Asthma. Sci. Immunol. 2017;2:eaam5446. doi: 10.1126/sciimmunol.aam5446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aam5446</ArticleId><ArticleId IdType="pmc">PMC5561743</ArticleId><ArticleId IdType="pubmed">28783702</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Laorden M.I., Stroo I., Terpstra S., Florquin S., Medema J.P., Va&#x144;t Veer C., De Vos A.F., Van Der Poll T. Expression and Function of Granzymes A and B in Escherichia Coli Peritonitis and Sepsis. Mediat. Inflamm. 2017;2017:4137563. doi: 10.1155/2017/4137563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/4137563</ArticleId><ArticleId IdType="pmc">PMC5485334</ArticleId><ArticleId IdType="pubmed">28694562</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias M.A., Jim&#xe9;nezdeBag&#xfc;es M.P., Aguil&#xf3; N., Menao S., Herv&#xe1;s-Stubbs S., deMartino A., Alcaraz A., Simon M.M., Froelich C.J., Pardo J. Elucidating Sources and Roles of Granzymes A and B during Bacterial Infection and Sepsis. Cell Rep. 2014;8:420&#x2013;429. doi: 10.1016/j.celrep.2014.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.06.012</ArticleId><ArticleId IdType="pubmed">25017060</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago L., Menaa C., Arias M., Martin P., Jaime-S&#xe1;nchez P., Metkar S., Comas L., Erill N., Gonzalez-Rumayor V., Esser E., et al. Granzyme A Contributes to Inflammatory Arthritis in Mice Through Stimulation of Osteoclastogenesis. Arthritis Rheumatol. 2017;69:320&#x2013;334. doi: 10.1002/art.39857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39857</ArticleId><ArticleId IdType="pubmed">27598995</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander G.M., Erwin K.L., Byers N., Deitch J.S., Augelli B.J., Blankenhorn E.P., Heiman-Patterson T.D. Effect of Transgene Copy Number on Survival in the G93A SOD1 Transgenic Mouse Model of ALS. Mol. Brain Res. 2004;130:7&#x2013;15. doi: 10.1016/j.molbrainres.2004.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molbrainres.2004.07.002</ArticleId><ArticleId IdType="pubmed">15519671</ArticleId></ArticleIdList></Reference><Reference><Citation>Acevedo-Arozena A., Kalmar B., Essa S., Ricketts T., Joyce P., Kent R., Rowe C., Parker A., Gray A., Hafezparast M., et al. A Comprehensive Assessment of the SOD1G93A Low-Copy Transgenic Mouse, Which Models Human Amyotrophic Lateral Sclerosis. Dis. Model. Mech. 2011;4:686&#x2013;700. doi: 10.1242/dmm.007237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.007237</ArticleId><ArticleId IdType="pmc">PMC3180233</ArticleId><ArticleId IdType="pubmed">21540242</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P., Braeken D., Callewaert G., Robberecht W., Van Den Bosch L. GluR2 Deficiency Accelerates Motor Neuron Degeneration in a Mouse Model of Amyotrophic Lateral Sclerosis. J. Neuropathol. Exp. Neurol. 2005;64:605&#x2013;612. doi: 10.1097/01.jnen.0000171647.09589.07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000171647.09589.07</ArticleId><ArticleId IdType="pubmed">16042312</ArticleId></ArticleIdList></Reference><Reference><Citation>Lev N., Barhum Y., Lotan I., Steiner I., Offen D. DJ-1 Knockout Augments Disease Severity and Shortens Survival in a Mouse Model of ALS. PLoS ONE. 2015;10:e0117190. doi: 10.1371/journal.pone.0117190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0117190</ArticleId><ArticleId IdType="pmc">PMC4379040</ArticleId><ArticleId IdType="pubmed">25822630</ArticleId></ArticleIdList></Reference><Reference><Citation>Staats K.A., Humblet-Baron S., Bento-Abreu A., Scheveneels W., Nikolaou A., Deckers K., Lemmens R., Goris A., Van Ginderachter J.A., Van Damme P., et al. Genetic Ablation of IP3 Receptor 2 Increases Cytokines and Decreases Survival of SOD1G93A Mice. Hum. Mol. Genet. 2016;25:3491&#x2013;3499. doi: 10.1093/hmg/ddw190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw190</ArticleId><ArticleId IdType="pmc">PMC5179944</ArticleId><ArticleId IdType="pubmed">27378687</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C.-H., Allen K., Oei F., Leoni E., Kuhle J., Tree T., Fratta P., Sharma N., Sidle K., Howard R., et al. Systemic Inflammatory Response and Neuromuscular Involvement in Amyotrophic Lateral Sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 2016;3:e244. doi: 10.1212/NXI.0000000000000244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000244</ArticleId><ArticleId IdType="pmc">PMC4897985</ArticleId><ArticleId IdType="pubmed">27308305</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9;s-Benito P., Moreno J., Dom&#xed;nguez R., Aso E., Povedano M., Ferrer I. Inflammatory Gene Expression in Whole Peripheral Blood at Early Stages of Sporadic Amyotrophic Lateral Sclerosis. Front. Neurol. 2017;8:546. doi: 10.3389/fneur.2017.00546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00546</ArticleId><ArticleId IdType="pmc">PMC5645505</ArticleId><ArticleId IdType="pubmed">29081763</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J., Yang X., Gao L., Zang D. Evaluating the Levels of CSF and Serum Factors in ALS. Brain Behav. 2017;7:e00637. doi: 10.1002/brb3.637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.637</ArticleId><ArticleId IdType="pmc">PMC5346523</ArticleId><ArticleId IdType="pubmed">28293476</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner F., Molawi K., Zychlinsky A. Mutant Superoxide Dismutase 1-Induced IL-1&#x3b2; Accelerates ALS Pathogenesis. Proc. Natl. Acad. Sci. USA. 2010;107:13046&#x2013;13050. doi: 10.1073/pnas.1002396107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002396107</ArticleId><ArticleId IdType="pmc">PMC2919927</ArticleId><ArticleId IdType="pubmed">20616033</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.D., McDonald T.S., Fung J.N.T., Woodruff T.M. Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the HSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2020;57:4143&#x2013;4155. doi: 10.1007/s12035-020-02019-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02019-9</ArticleId><ArticleId IdType="pubmed">32676989</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R.G., Henry Y.K., Mattson M.P., Appel S.H. Presence of 4-Hydroxynonenal in Cerebrospinal Fluid of Patients with Sporadic Amyotrophic Lateral Sclerosis. Ann. Neurol. 1998;44:696&#x2013;699. doi: 10.1002/ana.410440419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440419</ArticleId><ArticleId IdType="pubmed">9778272</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson E.P., Henry Y.K., Henkel J.S., Smith R.G., Appel S.H. Increased Lipid Peroxidation in Sera of ALS Patients. Neurology. 2004;62:1758&#x2013;1765. doi: 10.1212/WNL.62.10.1758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.62.10.1758</ArticleId><ArticleId IdType="pubmed">15159474</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H., Santella R., Liu X., Bogdanov M., Zipprich J., Wu H.C., Mahata J., Kilty M., Bednarz K., Bell D., et al. Oxidative Stress Biomarkers in Sporadic ALS. Amyotroph. Lateral Scler. 2008;9:177. doi: 10.1080/17482960801933942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960801933942</ArticleId><ArticleId IdType="pmc">PMC4332387</ArticleId><ArticleId IdType="pubmed">18574762</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J., Gonzalo I., Ruiz-Soto M., Berciano J. &#xbf;Por Qu&#xe9; Degeneran Las Motoneuronas? Actualizaci&#xf3;n En La Patogenia de La Esclerosis Lateral Amiotr&#xf3;fica. Neurolog&#xed;a. 2019;34:27&#x2013;37. doi: 10.1016/j.nrl.2015.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2015.12.001</ArticleId><ArticleId IdType="pubmed">26853842</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardo J., Bosque A., Brehm R., Wallich R., Naval J., M&#xfc;llbacher A., Anel A., Simon M.M. Apoptotic Pathways Are Selectively Activated by Granzyme A and/or Granzyme B in CTL-Mediated Target Cell Lysis. J. Cell Biol. 2004;167:457. doi: 10.1083/jcb.200406115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200406115</ArticleId><ArticleId IdType="pmc">PMC2172484</ArticleId><ArticleId IdType="pubmed">15534000</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman J. Granzyme A Activates Another Way to Die. Immunol. Rev. 2010;235:93&#x2013;104. doi: 10.1111/j.0105-2896.2010.00902.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2010.00902.x</ArticleId><ArticleId IdType="pmc">PMC2905780</ArticleId><ArticleId IdType="pubmed">20536557</ArticleId></ArticleIdList></Reference><Reference><Citation>Chico L., Ienco E.C., Bisordi C., Lo Gerfo A., Petrozzi L., Petrucci A., Mancuso M., Siciliano G. Amyotrophic Lateral Sclerosis and Oxidative Stress: A Double-Blind Therapeutic Trial After Curcumin Supplementation. CNS Neurol. Disord.-Drug Targets. 2018;17:767&#x2013;779. doi: 10.2174/1871527317666180720162029.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527317666180720162029</ArticleId><ArticleId IdType="pubmed">30033879</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedzielska E., Smaga I., Gawlik M., Moniczewski A., Stankowicz P., Pera J., Filip M. Oxidative Stress in Neurodegenerative Diseases. Mol. Neurobiol. 2016;53:4094. doi: 10.1007/s12035-015-9337-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9337-5</ArticleId><ArticleId IdType="pmc">PMC4937091</ArticleId><ArticleId IdType="pubmed">26198567</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowicka N., Juranek J., Juranek J.K., Wojtkiewicz J. Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2019;20:2616. doi: 10.3390/ijms20112616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112616</ArticleId><ArticleId IdType="pmc">PMC6600314</ArticleId><ArticleId IdType="pubmed">31141951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta Y., Nomura E., Shang J., Feng T., Huang Y., Liu X., Shi X., Nakano Y., Hishikawa N., Sato K., et al. Enhanced Oxidative Stress and the Treatment by Edaravone in Mice Model of Amyotrophic Lateral Sclerosis. J. Neurosci. Res. 2019;97:607&#x2013;619. doi: 10.1002/jnr.24368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24368</ArticleId><ArticleId IdType="pubmed">30565312</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino H. Edaravone for the Treatment of Amyotrophic Lateral Sclerosis. Expert Rev. Neurother. 2019;19:185&#x2013;193. doi: 10.1080/14737175.2019.1581610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2019.1581610</ArticleId><ArticleId IdType="pubmed">30810406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wosiski-Kuhn M., Lyon M.S., Caress J., Milligan C. Inflammation, Immunity, and Amyotrophic Lateral Sclerosis: II. Immune-Modulating Therapies. Muscle Nerve. 2019;59:23&#x2013;33. doi: 10.1002/mus.26288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26288</ArticleId><ArticleId IdType="pubmed">29979478</ArticleId></ArticleIdList></Reference><Reference><Citation>Mifflin L., Hu Z., Dufort C., Hession C.C., Walker A.J., Niu K., Zhu H., Liu N., Liu J.S., Levin J.Z., et al. A RIPK1-Regulated Inflammatory Microglial State in Amyotrophic Lateral Sclerosis. Proc. Natl. Acad. Sci. USA. 2021;118:e2025102118. doi: 10.1073/pnas.2025102118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2025102118</ArticleId><ArticleId IdType="pmc">PMC8020785</ArticleId><ArticleId IdType="pubmed">33766915</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Ibarburu S., Barreto-N&#xfa;&#xf1;ez R., Babdor J., Maciel T.T., Guillo M., Gros L., Dubreuil P., D&#xed;az-Amarilla P., Cassina P., et al. Post-Paralysis Tyrosine Kinase Inhibition with Masitinib Abrogates Neuroinflammation and Slows Disease Progression in Inherited Amyotrophic Lateral Sclerosis. J. Neuroinflamm. 2016;13:177. doi: 10.1186/s12974-016-0620-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0620-9</ArticleId><ArticleId IdType="pmc">PMC4940876</ArticleId><ArticleId IdType="pubmed">27400786</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora J.S., Genge A., Chio A., Estol C.J., Chaverri D., Hern&#xe1;ndez M., Mar&#xed;n S., Mascias J., Rodriguez G.E., Povedano M., et al. Masitinib as an Add-on Therapy to Riluzole in Patients with Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. Amyotroph. Lateral Scler. Front. Degener. 2020;21:5&#x2013;14. doi: 10.1080/21678421.2019.1632346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1632346</ArticleId><ArticleId IdType="pubmed">31280619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeldich E., Chen C.D., Boden E., Howat B., Nasse J.S., Zeldich D., Lambert A.G., Yuste A., Cherry J.D., Mathias R.M., et al. Klotho Is Neuroprotective in the Superoxide Dismutase (SOD1G93A) Mouse Model of ALS. J. Mol. Neurosci. 2019;69:264. doi: 10.1007/s12031-019-01356-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-019-01356-2</ArticleId><ArticleId IdType="pmc">PMC7008951</ArticleId><ArticleId IdType="pubmed">31250273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravnik-Glava&#x10d; M., Gori&#x10d;ar K., Vogrinc D., Koritnik B., Lavren&#x10d;i&#x10d; J.G., Glava&#x10d; D., Dol&#x17e;an V. Genetic Variability of Inflammation and Oxidative Stress Genes Affects Onset, Progression of the Disease and Survival of Patients with Amyotrophic Lateral Sclerosis. Genes. 2022;13:757. doi: 10.3390/genes13050757.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13050757</ArticleId><ArticleId IdType="pmc">PMC9140599</ArticleId><ArticleId IdType="pubmed">35627142</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;land L.-C., Markovinovic A., Jakovac H., De Marchi F., Bilic E., Mazzini L., Kriz J., Munitic I. Immunity in Amyotrophic Lateral Sclerosis: Blurred Lines between Excessive Inflammation and Inefficient Immune Responses. Brain Commun. 2020;2:fcaa124. doi: 10.1093/braincomms/fcaa124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa124</ArticleId><ArticleId IdType="pmc">PMC7585698</ArticleId><ArticleId IdType="pubmed">33134918</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon M.M., Hausmann M., Tran T., Ebnet K., Tschopp J., ThaHla R., M&#xfc;llbacher A. In Vitro- and Ex Vivo-Derived Cytolytic Leukocytes from Granzyme A X B Double Knockout Mice Are Defective in Granule-Mediated Apoptosis but Not Lysis of Target Cells. J. Exp. Med. 1997;186:1781&#x2013;1786. doi: 10.1084/jem.186.10.1781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.186.10.1781</ArticleId><ArticleId IdType="pmc">PMC2199142</ArticleId><ArticleId IdType="pubmed">9362539</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K.J., Schmittgen T.D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>